https://www.selleckchem.com/pr....oducts/aminoguanidin
a, Geranda EC Slager, Wiebren Zijlstra, Martin Stevens. Originally published in JMIR Rehabilitation and Assistive Technology (http//rehab.jmir.org), 27.04.2020.BACKGROUND Quality of life (QoL) is considered a key treatment outcome in bipolar disorder (BD) across research, clinical, and self-management contexts. Web-based assessment of patient-reported outcomes offer numerous pragmatic benefits but require validation to ensure measurement equivalency. A web-based version of the Quality of Life in Bipolar Disorder (Qo